Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
Source
CAS 1204390-13-5
Species
Homo sapiens
Expression system
Mammalian cells
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Dusigitumab,MEDI-573,IGF1, IGF2,anti-IGF1, IGF2
Reference
PX-TA1310
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG2-nd
Clonality
Monoclonal Antibody
Description of Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
General information on Anti-IGF1/IGF2[Homo sapiens] (Dusigitumab) Monoclonal Antibody
Dusigitumab has been investigated for the treatment of Cancer, Advanced Solid Malignancies, Unresectable or Metastatic Hepatocellular Carcinoma (HCC), and Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer.
Reviews
There are no reviews yet.